Previous work has elegantly demonstrated that, unlike adult mammalian heart, the neonatal heart is able to regenerate after injury from postnatal day (P) 1 to 7. Recently, macrophages are found to be required in the repair process as depletion of which abolishes endogenous regenerative capability of the neonatal heart. Nevertheless, whether innate immunity alone is sufficient for neonatal heart regeneration is obscure. Here, we source of chemokines and cytokines that attract monocytes and macrophages previously known to drive neonatal heart regeneration. Furthermore, Treg directly promote proliferation of both mouse and human cardiomyocytes in a paracrine manner. Our findings uncover an unappreciated mechanism in neonatal heart regeneration; and offer new avenues for developing novel therapeutics targeting Treg-mediated heart regeneration.
Introduction
Heart disease remains the leading cause of deaths worldwide. Yet the mammalian heart is notorious for its inability to repair and regenerate after injury; and the loss of cardiac muscle is replaced by scar tissues that further compromise heart function. Intriguingly, recent studies demonstrate that the mouse heart can transiently regenerate after birth till postnatal day 7 (P7) in a range of injury models including amputation of the ventricular apex via apical resection (AR) 1 , myocardial infarction (MI) 2 , cryoinfarction (CI) 3 and cardiomyocyte-specific cell death 4 . Importantly, neonatal heart regeneration is also observed in human 5 . In contrast to adults, neonatal cardiomyocytes can proliferate so the heart muscle is regenerated after injury with robust angiogenesis and minimal fibrosis 1, 6 .
Nevertheless, mechanisms driving neonatal heart regeneration are largely elusive. Since decades ago, the immune system has been known to orchestrate tissue repair as immune cells regulate both angiogenesis and fibrosis. Therefore, understanding how immune cells participate in neonatal heart regeneration would shed light on development of potential therapeutics to promote heart repair and regeneration.
During the last decade, innate immunity, particularly macrophages and their various polarization states, have been considered as a central regulator of the tissue healing processes. Indeed, previous studies demonstrate that macrophages are required in neonatal heart regeneration 4, 7 . Nonetheless, the role of adaptive immunity in neonatal heart regeneration has not been investigated. 15 .
In this study, we further investigate the unappreciated role of Treg in neonatal heart regeneration. We utilized CI as a major injury model because the fibrotic responses during neonatal heart repair resemble the healing processes of the adult heart. Unlike their wild type counterparts, T-cell deficient NOD/SCID mice failed to regenerate their injured myocardium at P3. Treg were recruited to cardiac muscle within the first week after injury. Treatment with the anti-CD25 antibody (clone PC61) that specifically depletes Treg led to increased cardiac fibrosis; while treatment with the anti-CD4
antibody (clone GK1.5) that specifically depletes conventional CD4 + T-cells reduced fibrosis in wild type neonatal hearts after injury. Our results of adoptive transfer experiments also indicate that Treg promoted neonatal heart regeneration in NOD/SCID mice after injury. Single cell transcriptomic profiling reveals that Treg are chemoattractive to innate immune cells including monocytes or macrophages.
Furthermore, Treg directly promote human and mouse cardiomyocyte proliferation in a paracrine manner.
Results

Innate immunity alone is insufficient for neonatal heart regeneration of NOD/SCID mice
Previous study shows that depletion of macrophages leads to excessive fibrosis and lack of neoangiogenesis after injury, resulting in compromised neonatal heart regeneration 7 .
Nevertheless, whether innate immune cells including macrophages are sufficient for neonatal heart regeneration is unanswered. To address this question, we induced CI as previously described 3, 17 to P3 (regenerating) or P8 (non-regenerating) neonatal mouse heart of NOD/SCID that harbors innate immune cells such as macrophages without functional adaptive immune cells such as T-cells. We then examined heart regeneration at day 28 post injury ( Fig 1A) . We used NOD/ShiLtJ (NOD) as a control of NOD/SCID because the latter is its descendant; and autoimmune diabetes does not occur during the study period (i.e. before 4-8 weeks of age). We also included ICR as an additional control because NOD is its descendant but ICR does not develop autoimmunity. Our results
showed that the P3 heart of both NOD and ICR regenerated better than their P8 counterparts (Fig 1B) , consistent with previous reports. However, both the P3 and P8
hearts of NOD/SCID did not regenerate ( Fig 1B) . We then quantified the degree of injury by Masson's trichrome staining that identifies collagen fibers. The P3 heart of NOD (Fig 1C, D) and ICR (Fig 1E, F) had significantly less fibrotic tissues than their P8 hearts, respectively. Compared to that of NOD, however, the P3 heart of NOD/SCID showed significantly more excessive scar tissue formation (Fig 1G, H) , suggestive of impaired neonatal heart repair. Furthermore, we also examined heart function at 2 months post injury by echocardiography ( Fig 1I) . Our data revealed that the P3 heart of NOD fully regenerated functionally as there was no significant difference in %fractional shortening between the CI and sham groups (Fig 1J) . On the other hand, the P3 heart of NOD/SCID showed significantly less functional regeneration by comparing with its sham control or the P3 heart of NOD ( Fig 1J) . Taken together, our findings showed that innate immune cells alone in NOD/SCID mice were insufficient for driving functional neonatal heart regeneration.
Loss-of-function of conventional CD4 + T-cells leads to reduced cardiac fibrosis
To ask if T-cells are recruited to the neonatal heart after injury, we first performed immunostaining for CD3 in the border zone at day 1 following CI to a P3 ICR heart. Our results demonstrated infiltration of CD3 + T-cells (Fig 2A) . We then asked which subsets of CD3 + T-cells responsible for neonatal heart regeneration as the absence of which in NOD/SCID mice contributed to impaired regeneration. We quantified infiltration of CD4 + or CD8 + T-cells after CI by flow cytometry. We found that there was a significant increase in absolute number of CD3 + CD4 + T-cells at days 7 and 14 after CI to a P8 heart compared to its sham control; yet there was no significant difference in absolute number of CD3 + CD4 + T-cells within the first two weeks after CI to a P3 heart compared to sham (Fig 2B) . Moreover, we did not observe significant difference in absolute number of CD3 + CD8 + T-cells within the first two weeks after CI to a P3 or P8 heart compared to sham ( Fig 2C) . Our findings indicated a potential role of CD4 + T-cells in determining the outcome of heart regeneration as they significantly infiltrated into the non-regenerating P8 heart but not the regenerating P3 heart after CI. To test this hypothesis, we respectively depleted CD4 + and CD8 + T-cells using the lytic anti-CD4 (clone GK1.5) and anti-CD8 (clone YTS169) antibodies after CI to a P8 heart and examined heart regeneration at day 28 post CI ( Fig 2D) . We confirmed highly efficient depletion by flow cytometry as CD3 + CD4 + ( Fig S1A) and CD3 + CD8 + (Fig S1B) T-cells were rarely present in the peripheral blood at day 28 after the use of respective antibody. Intriguingly,
Masson's trichrome staining demonstrated significantly reduced cardiac fibrosis in the GK1.5-treated compared to the untreated control or YTS169-treated group (Fig 2E, F) .
Moreover, results of immunostaining showed that scar tissue of the control or YTS169-treated group was rich in type-1 collagen (COLA1, Fig 2G) . To ask if GK1.5 improved heart regeneration by facilitating proliferation of cardiomyocytes, we performed immunostaining for proliferation marker (Ki67) and cardiac troponin T (cTnT) at the border zone. Our results revealed that there was significantly increased number of Ki67 + cTNT + cells in the GK1.5-treated compared to untreated control group (Fig 2H) .
Together, depletion of CD4 + T-cells promoted regeneration of the P8 heart after injury. Fig 3D, Fig S2) 15,19
. Treatment with PC61 significantly increased cardiac fibrosis (Fig 3E, F ) and COLA1 deposition ( Fig 3G) ; and significantly reduced cTnT + myocardium in the infarct zone (Fig 3G, H) and lessened Ki67 + cTnT + proliferating cardiomyocytes in the border zone at day 28 post CI ( Fig 3I, J) . Altogether, our loss-offunction experiments showed that ablation of Treg impaired the endogenous regenerative capability of a P3 heart after CI.
Adoptive transfer of FOXP3 + Treg promotes neonatal heart regeneration of
NOD/SCID mice
To further confirm the role of Treg in neonatal heart regeneration, we purified 1 million FOXP3 + (hCD2 + ) Treg from the spleen of NOD.Foxp3 hCD2 mice for adoptive transfer via intraperitoneal injection as previously described 20 into NOD/SCID mice so the recipients only harbored Treg without other conventional T-cells (Fig 4A) . By flow cytometric analysis on day 7 following adoptive transfer, we found that about 88% of total CD3 + CD4 + T-cells were hCD2 + Treg in the spleen and heart, respectively ( Fig 4B) .
Moreover, we also quantified engraftment of CD3 + CD4 + hCD2 + Treg weekly during the first 4 weeks following adoptive transfer and found that the %FOXP3 + Treg among total splenocytes increased gradually and reached about 5% by day 28 post adoptive transfer (Fig 4C) , similar to a wild type mouse.
We then performed CI to P3 heart of FOXP3 + Treg-infused or control NOD/SCID mice;
and examined heart regeneration at day 28 post CI ( Fig 4A) (Fig 4G) . To evaluate heart regeneration functionally, we performed echocardiography at day 28 post CI ( Fig 4H) . Our data revealed that adoptive transfer of Treg significantly increased %fractional shortening compared to control (Fig 4I) . We also included an additional injury model to recapitulate the role of Treg in neonatal heart regeneration. AR was performed on P3 heart of FOXP3 + Treg-infused or control NOD/SCID mice; and heart regeneration was examined on day 28 post injury ( Fig S3A) .
Similarly, we demonstrated that adoptive transfer of Treg reduced cardiac fibrosis ( Fig   S3B) and significantly increased Ki67 + cTnT + cardiomyocytes (Fig S3C) after injury compared to control. Altogether, our gain-of-function experiments in both CI and AR models uncovered an unappreciated role of Treg in potentiating neonatal heart regeneration.
Single cell transcriptomic profiling reveals Foxp3 + Treg as a source of paracrine factors
In order to understand how Treg regulate neonatal heart regeneration, we performed genome-wide single-cell transcriptomic profiling (scRNA-seq) as recently described 21, 22 with CD3 + T-cells purified at day 7 following injury of ICR mice that underwent CI at P3.
In this study, the spleen served as a source of naïve T-cells (control) while the heart served as a source of neoantigen-activated T-cells. We purified about ~1850 and ~581 CD3 + T-cells from the spleen and heart, respectively, by flow cytometry. We then focused our analysis on Foxp3 + Treg and performed unsupervised analysis that did not rely on any known marker. t-distributed stochastic neighbor embedding (t-SNE) plots
showed that Treg of spleen and heart formed distinct populations (Fig 5A) : splenic Treg mainly constituted cluster C1; while heart Treg primarily formed cluster C2. We identified the most significantly upregulated genes in C1 and C2 ( (Fig 5D) .
To validate our scRNAseq data, we asked if Treg recruited macrophages during neonatal heart regeneration. We performed flow cytometric analysis to determine macrophage coverage in the neonatal heart of NOD/SCID mice 14 days after CI at P3 (Fig 5E) . In this study, we examined if adaptive immune cells particularly T-cells mediate neonatal heart regeneration after injury because our results showed that innate immune cells including macrophages were insufficient to drive functional regeneration without the presence of T-cells in NOD/SCID mice. We then asked which subset of T-cells is important for neonatal heart regeneration. In wile type mice, we found that there was no significant infiltration of CD8 + T-cells into the infarcted myocardium after CI compared to that of the sham-operated control; and depletion of which did not alter the healing processes, suggesting that CD8 + T-cells were not likely required for neonatal heart regeneration. Instead, we found significant infiltration of CD4 + T-cells after CI to a P8
heart that was unable to regenerate compared to the sham-operated control. Depletion of CD4 + T-cells via the lytic GK1.5 antibody leads to significantly reduced cardiac fibrosis and enhanced cardiomyocyte proliferation of a P8 heart after CI, indicating that CD4 + T- antibody after CI to a regenerating P3 heart of NOD mice led to impaired heart regeneration manifested by significantly increased cardiac fibrosis and reduced number of proliferating cardiomyocytes compared to the untreated control. For gain-of-function experiments, we generated the Foxp3 hCD2 reporter mice in NOD background as a source of hCD2 + Treg for adoptive transfer into NOD/SCID mice. Engraftment of Treg contributed to significantly reduced cardiac fibrosis, increased number of proliferating cardiomyocytes and enhanced cardiac function 4 weeks after CI to a non-regenerating P3
heart of NOD/SCID mice compared to control. Similarly, adoptive transfer of Treg also promoted neonatal heart regeneration of NOD/SCID mice in an additional injury model, AR.
Mechanistically, single cell transcriptomic profiling revealed that Treg of a regenerating P3 heart were a source of chemokines and cytokines that could recruit monocytes and macrophages, previously reported to drive neonatal heart regeneration. We validated this by flow cytometric analysis on macrophages 2 weeks after CI to a P3 heart of NOD/SCID in the Treg-infused group compared to that of the Treg-deficient control. 
Materials and Methods
Mice
Neonatal mouse heart cryoinfarction (CI)
CI was performed as previously described 17 . Briefly, neonatal mice at P3 or P8 were subjected to anesthesia by freezing for 3-5 minutes, and were then placed on the frozen operation table once breathing was steady. Mouse limbs were fixed in location with forceps and 70% ethanol was applied to disinfect the surgical area. An incision ( 1 cm) was made along the sternum and vertical of the chest muscles under a stereomicroscope.
Two or three intercostal incisions were made in the left sternum chest to separate the pericardium and expose the left ventricle. Blunt port copper wire (1 mm thickness) was frozen in liquid nitrogen and then put on the left ventricle in order to induce frostbite; this was maintained for 7-8 seconds until the left ventricle appeared white. After injury, bubbles and blood in the chest were squeezed out. The chest was closed and the skin was sewn up with 8-0 sutures. After surgery, neonatal mice were placed under a 37°C heating pad to keep warm. They were then placed back with their mothers as soon as they woke up and the skin color returned to normal. In the sham-operated control, we performed the same experimental procedures as above except that we replaced liquid nitrogen with PBS at room temperature.
Neonatal mouse heart apical resection (AR)
AR was performed as previously described 17 . Briefly, neonatal mice at P3 were subjected to anesthesia by freezing for 3-5 minutes, and were then placed on the frozen operation table once breathing was steady. Mouse limbs were fixed in location with forceps and 70% ethanol was applied to disinfect the surgical area. An incision ( 1 cm) was made along the sternum and vertical of the chest muscles under a stereomicroscope. Two or three intercostal incisions were made in the left sternum chest to separate the pericardium and expose the apex. Curved forceps were extended into the intrathoracic to pull out the heart and the apex was then truncated with microsurgical scissors. After injury, bubbles and blood in the chest were squeezed out. The chest was closed and the skin was sewn up with 8-0 sutures. After surgery, neonatal mice were placed under a 37°C heating pad to keep warm. They were then placed back with their mothers as soon as they woke up and the skin color returned to normal. In the sham-operated control, we performed the same experimental procedures as above except that we did not truncate the heart apex.
Adoptive transfer of Treg
Treg were purified from the spleen of 4-6 weeks old Foxp3 hCD2 mice using anti-hCD2 magnetic beads following the manufacturer's instructions (Miltenyi Biotech). Each neonatal NOD/SCID mouse was adoptively transferred with 1 million Treg through intraperitoneal (i.p.) injection immediately after CI, AR or sham surgery.
Administration of mAb
Lytic anti-CD4 (clone GK1.5, BioxCell), lytic anti-CD8 (clone YTS169, BioxCell) and lytic anti-CD25 (clone PC61, BioxCell) mAbs were used as previously described 19, 35 . Briefly, YTS177 was injected i.p. at 0.4 mg/pup on days 0, 7, 14 and 21 following CI; and GK1.5 or YTS169 was injected i.p. at 0.2 mg/pup on days 0, 2, 4, 6 and 10 following CI. PC61 was injected i.p. at 0.5 mg/pup on days 0, 2, 4, 6 and 10 following CI.
Echocardiography
The left ventricle systolic function was measured 2 months following CI or sham operation with echocardiography in mice via a digital ultrasound system (Vevo2100 Imaging System, VisualSonics). Conventional measurements of the left ventricle (LV) included: end-diastolic diameter (LVEDD), end-systolic diameter (LVESD), intraventricular septal thickness (IVST), posterior wall thickness (LVPWT), ejection fraction (LVEF) and fractional shortening (LVFS). Analysis was performed with VisualSonics Vevo2100 software.
Immunostaining
Heart tissues were dissected and fixed in 4% paraformaldehyde at 4°C overnight. The fixed tissues were washed three times with PBS and equilibrated in 30% sucrose at 4°C for 2 days before freezing and cryosectioning. Eight micrometer frozen sections were blocked at 2% goat serum and then stained with the respective primary antibodies at 10 ug/ml at 4˚C overnight. Anti-mouse primary antibodies used: COLA1 (abcam, ab34710), cTNT (abcam, ab8295) and Ki67 (eBiosciences 14-5698-82). Anti-human primary antibodies used: cTNT (RnD systems, MAB1874) and Ki67 (abcam, ab15580). AlexaFluor-488-or Alexa-Fluor-546-conjugated secondary antibodies (Invitrogen) were used at room temperature for 30 minutes in the dark. Slides were mounted with DAPIcontaining fluorescence mounting medium (Dako) and fluorescence was detected with an upright fluorescence microscope, inverted fluorescence microscope or confocal microscope (all Leica). Images were processed with ImageJ software and cTNT coverage was analyzed based on this formula: cTNT + area/total area.
Masson's trichrome staining
Masson's trichrome staining was performed to determine collagen deposition per manusfacturer's instruction (Polysciences 25088-1). Briefly, frozen sections were washed in PBS and fixed in 4% paraformaldehyde for 8 min. Slides were then incubated in
Bouins' solution (5% acetic acid, 9% formaldehyde and 0.9% picric acid) at room temperature overnight. The next day after washed with distilled water, slides were incubated in Weigert's iron hematoxylin solution for 10 minutes, washed and then stained with Biebrich scarlet-acid fuchsin for 5 minutes. After three washes with distilled water, slides were incubated in phosphotungstic/phosphomolybdic acid for 10 minutes followed by staining with aniline blue solution for 5 minutes. After that, slides were washed with distilled water for three times and dehydrated with ethanol and xylene based on standard procedures. Images were acquired on Nikon eclipse TE2000-S microscope.
For the CI group, images were analyzed and fibrosis coverage was quantified based on this formula: scar perimeter/total perimeter.
Flow cytometry, cell sorting and analysis
To collect splenocytes, the excised spleen was dissociated in PBS with a syringe plunger through a 40um cell strainer to obtain single cell suspension. To study immune cell infiltrates in the neonatal heart, heart tissues were minced into small fragments and dissociated with 1:1 type II collagenase (1000 U/ml in PBS, Worthington) and dispase 
Cell cultures
For Treg, naïve CD3 + CD4 + hCD2 + Treg were purified from the spleen of 4-6 week old For murine neonatal cardiomyocytes, they were isolated with an enzymatic digestion approach as previously described 37 . Briefly, P1 ventricles were minced into small fragments and pre-digested in 0.05% trypsin-EDTA at 4°C overnight. The pre-digested mixture was washed with 10 mM HEPES and 1X penicillin/streptomycin-containing DMEM/F12 medium (light medium) pre-warmed at 37°C, followed by repeated digestions in a stepwise manner: the tissues were digested with 100 U/ml type II collagenase at 37°C for 10 minutes. After that, the supernatant was collected and mixed in a ratio of 1:1 with DMEM/F12 medium supplemented with 10mM HEPES, 1X
penicillin/streptomycin, 10% horse serum (Invitrogen) and 5% fetal bovine serum (dark medium). The supernatant mixture was then kept on ice and the tissue pellet was further digested for 2-3 times with the same procedures until the tissues became single cells. All supernatant mixtures were then pooled together and centrifuged at 800 rpm for 5 minutes.
Differential plating was performed to remove fibroblasts by resuspending the cell pellet with 10 ml dark medium followed by seeding onto a T25 flask at 37°C for 1 hour. After that, the unattached cells were transferred to a new T25 and replated at 37°C for another hour. The unattached cardiomyocytes were then centrifuged at 400 rpm for 5 minutes, and resuspended with appropriate volume of dark medium for cell counting.
Cardiomyocytes were plated on Matrigel (1:100 in DMEM/F12)-coated chamber slide at a density of 10,000 cells per well and cultured in dark medium at 37°C for 24 hours. To synchronize proliferation of cardiomyocytes before experiment, they were starved with serum-free medium overnight. After that, they were cocultured with in vitro stimulated Treg in a ratio of cardiomyocytes: Treg as 3:1, Treg supernatant-containing dark medium
(1:1) or 50 ng/ml murine recombinant amphiregulin (RnD systems, 989-AR-100) at 37°C
for 1 day before analysis.
For human cardiomyocytes, cardiomyocytes were derived from hESCs as previously described 31
. Cardiomyocytes were generated with a sequential administration of growth factors ( Fig 6C) . Briefly, hESCs were seeded at a density of 3.75 x 10 4 cells/cm 2 on matrigel (BD, growth factor reduced, 1:60)-coated plate in mTeSR TM (Stemcell Technologes) supplemented with 10 uM Y-27632 (Selleck Chem, S1049) and 1uM CHIR99021 (Selleck Chem,S2924). On the day of mesoderm induction, cells were overlaid with Matrigel (1:60) and 100 ng/ml Activin A (Peprotech, 120-14E) in insulinfree B27-containing RPMI1640 medium (RPMI/B27-) for 24 hours, followed by 1uM CHIR99021 and 5 ng/ml BMP-4 (Peprotech, AF-120-05ET) for 48 hours. Subsequently, the medium was refreshed and supplemented with 5 uM IWR-1 (Calbiochem, 681669) for 48 hours, followed by unsupplemented RPMI/B27-medium for 48 hours. On day 7, cardiac progenitors were expanded and maintained in insulin + B27-containing RPMI1640 medium (RPMI/B27+). The medium was refreshed every 3 days. Beating cardiomyocytes could often be observed on day 14 of differentiation. To synchronize proliferation of cardiomyocytes, beating cardiomyocytes were starved in RPMI1640 alone for 9 hours followed by replenishment with RPMI/B27+ alone, supernatant of Treg cultures or 50 ng/ml human recombinant amphiregulin (Peprotech, 100-55B) for 3 days before analysis. K is the number of clusters). Gene ontology (GO) enrichment analyses of the clusterspecific highly expressed genes were performed by DAVID Bioinformatics Resources (v6.8) 39 .
Single-cell encapsulation and library preparation
Statistical analysis
The data were expressed as arithmetic mean±S.E.M. of biological replicates (n = 5, unless otherwise specified) performed under the same conditions. Statistical analysis was performed using the unpaired student's t-test with data from two groups; while date from more than two groups was performed using an ANOVA followed by Tukey's method for multiple comparisons. Significance was accepted when P < 0.05. Data are presented as mean±S.E.M., *P<0.05, **P<0.01, ***P<0.001, n=3 per group. Table 1 The most significantly upregulated genes expressed by heart Treg during neonatal heart regeneration. Foxp3 + Treg are purified from the spleen or heart at day 7 post CI to P3 ICR mice. C1: upregulated genes in splenic naïve Treg; C2: upregulated genes in Treg following activation by neoantigens released during cryoinfarction in the heart.
Cluster
Significantly upregulated genes C1 Elane, Mpo, Prtn3, Fcnb, Ngp, Kpna2, Lcn2, S100a8, S100a9, Camp, BC100530, Stfa3, Ccnb1, Wfdc21, Ltf, Ube2c, Cenpf, Gm5483, Cdc20, Lockd, Ccnb2, Cdc25b, Tubb4b, Cdk1, Cd6, Retnlg, Def6, 
